You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盈健醫療(01419.HK)2022財年淨利3.75億港元 同比增加約159.8%
格隆匯 09-29 22:43

格隆匯9月29日丨盈健醫療(01419.HK)公吿,集團於2022財年收益約為11.2億港元,較2021財年增加約71.3%。公司擁有人應占溢利約為3.75億港元,同比增加約159.8%。每股基本盈利約為98.9港仙。擬宣派30港仙的末期股息。

公司擁有人應占溢利增加主要由於(i)全科醫療服務收益增加,此乃由於對預防、檢測、疫苗接種及外展服務,當中包括疫情相關的服務需求持續上升;(ii)收益增加以致毛利上升;及(iii)應課税收入增加導致所得税開支增加抵銷所致。

就檢測服務而言,集團於2022財年為公眾提供各項檢測選項。集團所有全科醫務中心皆提供檢測服務。同時,在與香港政府及其他合作認可機構的支持下,集團繼續在香港多個指定地點提供新型冠狀病毒檢測服務。集團配合其流動採樣檢測車及優秀的外展團隊,為包括社區檢測中心、流動採樣站、圍封強檢大廈、醫院、企業、護老院及學校等地點提供檢測服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account